Personally, if it wasnt for the great promise of Ponatinib I would have been out of here a long time ago. However, if Rida doesnt fail, I may be here for a number of years as I do believe that the third molecule will be another blockbuster, as strong as Ponatinib. Rida is the weak sister, and if we get past this it all looks good.... I think that the near term will bring up to 15 but the long term much higher, and although I will sell some in the mid teens, I will hold at least half as Ponatinib isnt the whole story.
News 
Market Data 
Discover 
